Special ReportsAll NewsFDA BriefsOncology IconsThe Targeted PulseVoices from the Field
Conference CoverageConference ListingData Dialogue with the Oncology Brothers
All VideosCase-Based Peer PerspectivesEvolving Paradigms in OncologyExpert Perspective Virtual Tumor BoardInterviewsInvestigator PerspectivesMedical World NewsPersonalized MedicinePivotal Practice Views with the Oncology BrothersPodcastsSpeaking Out
All PublicationsEvolving ParadigmsPeers & Perspectives in OncologyTargeted Therapies in Oncology
CASE-BASED ROUNDTABLEPARTNERS
CME/CEClinical TrialsEventsPrecision Medicine PerspectivesPress ReleasesSponsored ContentTreatment Resources
SUBSCRIBE
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
Spotlight -
  • Myeloma
  • Chronic Lymphocytic Leukemia
  • Gynecologic Cancers
  • Genomic Testing
  • Melanoma
  • Genitourinary Cancers
BRAIN CANCER
BREAST CANCERBREAST CANCER
GENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERSGENITOURINARY CANCERS
GENOMIC TESTINGGENOMIC TESTING
GI CANCERSGI CANCERSGI CANCERSGI CANCERSGI CANCERS
GYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERSGYNECOLOGIC CANCERS
HEAD & NECK CANCERS
HEMATOLOGYHEMATOLOGY
IMMUNOTHERAPYIMMUNOTHERAPY
LEUKEMIASLEUKEMIASLEUKEMIASLEUKEMIAS
LUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCERLUNG CANCER
LYMPHOMASLYMPHOMASLYMPHOMASLYMPHOMAS
MPNs
MULTIPLE MYELOMA
NTRK GENE FUSIONS
SARCOMA
SKIN CANCERSSKIN CANCERS
THYROID CANCERS
    • CASE-BASED ROUNDTABLE
    • PARTNERS
    • SUBSCRIBE

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Gynecologic Cancers: Case 2

home / case-based-peer-perspectives / gyn-feb-2015-case-2

Gynecologic Cancers


Bradley J. Monk, MD, FACOG, FACS: Key Parameters to Determine Therapy

EP. 1: Bradley J. Monk, MD, FACOG, FACS: Key Parameters to Determine Therapy

June 17th 2015

Watch


Bradley J. Monk, MD, FACOG, FACS: Safety Concerns Regarding Treatment

EP. 2: Bradley J. Monk, MD, FACOG, FACS: Safety Concerns Regarding Treatment

June 17th 2015

Watch


Bradley J. Monk, MD, FACOG, FACS: Patient Characteristics to Consider

EP. 3: Bradley J. Monk, MD, FACOG, FACS: Patient Characteristics to Consider

June 17th 2015

Watch


Bradley J. Monk, MD, FACOG, FACS: Adding Bevacizumab to Cisplatin/Paclitaxel in Patient

EP. 4: Bradley J. Monk, MD, FACOG, FACS: Adding Bevacizumab to Cisplatin/Paclitaxel in Patient

June 17th 2015

Watch


Bradley J. Monk, MD, FACOG, FACS: Data in Support of Adding Antiangiogenesis Therapy To Current Treatment

EP. 5: Bradley J. Monk, MD, FACOG, FACS: Data in Support of Adding Antiangiogenesis Therapy To Current Treatment

June 17th 2015

Watch


Krishnansu S. Tewari, MD, FACOG, FACS: Key Parameters to Determine Therapy

EP. 6: Krishnansu S. Tewari, MD, FACOG, FACS: Key Parameters to Determine Therapy

June 17th 2015

Watch


Krishnansu S Tewari, MD, FACOG, FACS: Safety Concerns Regarding Treatment

EP. 7: Krishnansu S Tewari, MD, FACOG, FACS: Safety Concerns Regarding Treatment

June 17th 2015

Watch


Krishnansu S Tewari, MD, FACOG, FACS: Patient Characteristics to Consider

EP. 8: Krishnansu S Tewari, MD, FACOG, FACS: Patient Characteristics to Consider

June 17th 2015

Watch


Krishnansu S. Tewari, MD, FACOG, FACS: Adding Bevacizumab to Cisplatin/Paclitaxel in Patient

EP. 9: Krishnansu S. Tewari, MD, FACOG, FACS: Adding Bevacizumab to Cisplatin/Paclitaxel in Patient

June 17th 2015

Watch


Krishnansu S. Tewari, MD, FACOG, FACS: Data in Support of Adding Antiangiogenesis Therapy To Current Treatment

EP. 10: Krishnansu S. Tewari, MD, FACOG, FACS: Data in Support of Adding Antiangiogenesis Therapy To Current Treatment

June 17th 2015

Watch

About Us
Advertise
Contact Us
CureToday.com
CancerNetwork.com
OncLive.com
OncNursingNews.com
Do Not Sell My Information
Privacy
Terms & Conditions
Editorial Board
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.